ArticleBMC endocrine disorders2026
Elevated parathyroid hormone levels in normocalcemic patients after parathyroidectomy for primary hyperparathyroidism: what risk factors should be considered?
Article in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveNormocalcemia with elevated parathyroid hormone levels (NCePTH) after successful parathyroidectomy in patients with primary hyperparathyroidism (PHPT) has drawn attention during the postoperative period and remain a clinical conundrum. PATIENTS AND
methodsWe retrospectively studied 539 consecutive patients with PHPT who underwent parathyroid surgery from August 2017 to December 2023.
resultsThe mean age of the patients was 53.3 years, and 66.3% of the patients were female. After a median follow-up of 12 months, 9.9% of the patients were diagnosed with NCePTH. Compared with patients who were cured after surgery, those with NCePTH had high preoperative serum PTH levels (median [quartile], 228 pg/mL [126, 387] vs. 150 pg/mL [108.65, 251.5], p = 0.039) and PTH levels on the first postoperative day (median [quartile], 23.5 pg/mL [8.1, 35.6] vs. 9.7 pg/mL [4, 21.15], p = 0.000). Patients with NCePTH after surgery did not differ from those with normal PTH levels in terms of sex, age, body mass index, history of thyroid/parathyroid surgery, calcium, phosphorus, and creatinine levels and parathyroid lesion size. According to the multivariable analysis, a preoperative PTH concentration ≥ 191 pg/mL (odds ratio [OR], 8.78; p = 0.003) and PTH concentration ≥ 16.4 pg/mL (odds ratio [OR], 12.47; p = 0.0004) on the first day after surgery remained risk factors for NCePTH.
conclusionsThe incidence rate of NCePTH after successful parathyroidectomy in patients with PHPT was 9.9%. A preoperative PTH concentration ≥ 191 pg/mL and a PTH concentration ≥ 16.4 pg/mL on the first day after surgery were identified as risk factors for NCePTH after parathyroidectomy. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.